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PHypertension
Pulse Wave Velocity Is an Independent
Predictor of the Longitudinal Increase in Systolic
Blood Pressure and of Incident Hypertension
in the Baltimore Longitudinal Study of Aging
Samer S. Najjar, MD,* Angelo Scuteri, MD, PHD,*† Veena Shetty, MPH,* Jeanette G. Wright, BA,‡
Denis C. Muller, MS,‡ Jerome L. Fleg, MD, FACC,§ Harold P. Spurgeon, PHD,*
Luigi Ferrucci, MD, PHD,‡ Edward G. Lakatta, MD*
Baltimore and Bethesda, Maryland; and Rome, Italy
Objectives This study sought to evaluate whether pulse wave velocity (PWV), a noninvasive index of arterial stiffness, is a
predictor of the longitudinal changes in systolic blood pressure (SBP) and of incident hypertension.
Background Although arterial stiffness is believed to underlie, in part, the age-associated changes in SBP, particularly at
older ages, few longitudinal studies in humans have examined the relationship between arterial stiffness and
blood pressure.
Methods Pulse wave velocity was measured at baseline in 449 normotensive or untreated hypertensive volunteers (age
53  17 years). Repeated measurements of blood pressure were performed during an average follow-up of
4.9  2.5 years.
Results After adjusting for covariates including age, body mass index, and mean arterial pressure, linear mixed effects
regression models showed that PWV was an independent determinant of the longitudinal increase in SBP
(p  0.003 for the interaction term with time). In a subset of 306 subjects who were normotensive at baseline,
hypertension developed in 105 (34%) during a median follow-up of 4.3 years (range 2 to 12 years). By stepwise
Cox proportional hazards models, PWV was an independent predictor of incident hypertension (hazard ratio 1.10
per 1 m/s increase in PWV, 95% confidence interval 1.00 to 1.30, p  0.03) in individuals with a follow-up dura-
tion greater than the median.
Conclusions Pulse wave velocity is an independent predictor of the longitudinal increase in SBP and of incident hypertension.
This suggests that PWV could help identify normotensive individuals who should be targeted for the implementa-
tion of interventions aimed at preventing or delaying the progression of subclinical arterial stiffening and the
onset of hypertension. (J Am Coll Cardiol 2008;51:1377–83) © 2008 by the American College of Cardiology
Foundation











ohe incidence and prevalence of hypertension increase with
dvancing age. Hypertension afflicts approximately 50 mil-
ion individuals in the U.S. and over 1 billion individuals
orldwide (1). Furthermore, hypertension is associated with
ncreased morbidity and mortality (2). Among hypertensive
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007, accepted October 15, 2007.ubjects with at least 1 other cardiovascular risk factor, the
-year incidence of fatal and nonfatal myocardial infarction
s 11%, and the 6-year incidence of total cardiovascular
vents is 33% (3). These rates are likely underestimates
ecause hypertension is under-recognized and inadequately
reated in the community (4). Thus, strategies to identify
ormotensive subjects who are at increased risk for devel-
ping hypertension as they age and efforts to elucidate the
echanisms that underlie this increased risk are critical to
he development and implementation of measures that may
ffectively delay or prevent hypertension.
Carotid-femoral pulse wave velocity (PWV) is a marker
f central arterial stiffness that can be measured noninva-
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in healthy subjects (5), and an
independent predictor of mortality
in the general population (6), in
hypertensive subjects (7), in older
community-dwelling (8) and hos-
pitalized (9) individuals, and in
patients with end-stage renal dis-
ease (10). Both age (11) and dis-
tending blood pressure (BP) (12)
are major determinants of PWV.
It is believed that age-associated
arterial stiffening is accelerated by
chronic elevations in BP caused by
structural and functional alter-
ations in the walls of the central
elastic arteries (13). In turn, arte-
rial stiffness is believed to underlie,
in part, the age-associated changes
in systolic blood pressure (SBP)
nd diastolic blood pressure (DBP), particularly at older ages
14). To the best of our knowledge, the relationship between
WV and the longitudinal changes in BP has not been
eported. Thus, the aims of this study were to evaluate
hether, in healthy volunteers, PWV is an independent
redictor of the longitudinal changes in SBP and of incident
ypertension.
ethods
tudy population. The BLSA (Baltimore Longitudinal
tudy of Aging) is a prospective study of community-
welling volunteers who undergo approximately 21⁄2 days of
edical, physiological, and psychological examinations at
egular intervals (15). Pulse wave velocity was performed on
subset of 714 BLSA participants, chosen in a random
ashion on days when testers were available, and who were
ree of overt coronary artery disease as defined by history of
ngina pectoris, documented myocardial infarction, or
ajor Q waves on resting electrocardiograms (Minnesota
ode 1:1 or 1:2). Of those, 92 were excluded from this
nalysis because they were on concurrent BP-lowering
edications at the time of the PWV measurement, 17 were
xcluded because of missing covariates, and 156 were
xcluded because they did not have any follow-up visit. All
ubjects signed an informed consent at each study visit.
ariables measured. Height and weight were determined
or all participants. Body mass index (BMI) was calculated
s body weight (kg)/height2 (m2). Smoking status was
scertained by a questionnaire. Total and fractionated cho-
esterol, triglycerides, and plasma glucose were determined
n the fasting state as previously described (16).
Blood pressure determinations were performed in the
orning, after a light breakfast, with subjects in the seated
osition, after a 5-min quiet resting period. Brachial BP was
Abbreviations
and Acronyms
BMI  body mass index
BP  blood pressure
CI  confidence interval





HR  hazard ratio
MAP  mean arterial
pressure
PP  pulse pressure
PWV  pulse wave velocity
SBP  systolic blood
pressureeasured in triplicate by auscultation in both arms with a wercury sphygmomanometer using an appropriately sized
uff. The BP values used in this study are the average of the
econd and third measurements on both the right and left
rms. Values for SBP and DBP were defined by Korotkoff
hases I and V, respectively. Pulse pressure (PP) was
omputed as PP  (SBP  DBP); mean arterial pressure
MAP) was computed as MAP  DBP  (1/3  PP).
Pulse wave velocity was measured using nondirectional
ranscutaneous Doppler probes (model 810A, 9 to 10-
hz probes, Parks Medical Electronics, Inc., Aloha,
regon) as previously described (11): A minimum of 10
rterial flow waves from the right common carotid artery
nd the right femoral artery were simultaneously re-
orded, and were averaged using the QRS for synchro-
ization. Pulse wave velocity was calculated as the dis-
ance traveled by the flow wave (measured with an
xternal tape measure over the body surface) divided by
he time differential between the feet of simultaneously
ecorded carotid and femoral arterial flow waves.
tatistical analyses. All analyses were performed using the
AS package (version 8.1, SAS Institute Inc., Cary, North
arolina). Data are presented as mean  SD or propor-
ions. Comparisons between groups were performed using
hi-square tests for categorical variables and two-sample
tests for continuous variables.
The predictors of SBP at the last visit were evaluated with
ultiple regression analyses. The longitudinal changes in
BP (and PP) were analyzed with linear mixed effects
egression models (17), which easily accommodate unbal-
nced, unequally spaced observations (18), and consequently
re ideal tools for analyzing longitudinal BLSA data
16,19). In these models, the dependent variable (i.e., SBP
r PP) was assessed on the baseline visit and during all
ollow-up visits, whereas the independent variables were
nly measured on the baseline visit. The following variables,
easured or calculated on the baseline visit, were entered
nto all of the models as fixed effects: age, age2, gender, race,
moking, BMI, heart rate, MAP, total and high-density
ipoprotein (HDL) cholesterol, triglycerides, fasting plasma
lucose, and PWV.
In mixed-effects regression models, the interaction term
etween a fixed effect variable and time evaluates whether
his variable is a predictor of the longitudinal changes in the
ependent BP variable. Thus, the interaction terms between
ime and all of the aforementioned fixed effect variables were
valuated, but only the statistically relevant (p  0.1) ones
ere included in the models.
All models also included intercept and time as random
erms. Random effects allow each participant’s beginning
alue to vary from the population average (intercept) and the
ongitudinal trajectory to vary from the population average
ongitudinal trajectory (slope). No structure was imposed on
he covariance matrix of these random effects, and the errors
ere assumed to be independent with constant variance.
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April 8, 2008:1377–83 Pulse Wave Velocity and Blood Pressureg) at baseline, incident hypertension (HTN) was defined
s SBP 140 mm Hg, or DBP 90 mm Hg, or the use of
ntihypertensive medications on a follow-up visit. The
ariables that predicted the future development of HTN
ere evaluated with Cox proportional hazards models. In a
rst set of models, it was noted that the interaction term
etween duration of follow-up and PWV was significant
p  0.0001), indicating that PWV’s ability to predict
ncident HTN differed according to the duration of follow-
p. The cohort was therefore stratified according to median
ollow-up duration. Within each stratum, stepwise Cox
odels were constructed in which age and baseline SBP
ere forced into the models because they are well estab-
ished predictors of HTN, and the following variables were
dded in a stepwise forward manner, whereby only the
tatistically significant ones were retained in the models:
ender, race, smoking, BMI, DBP, PWV, heart rate, total
holesterol, HDL cholesterol, triglycerides, and glucose.
he proportionality assumption was confirmed for these
odels.
esults
he baseline characteristics of the study cohort stratified by
ender are shown in Table 1. These normotensive and
ntreated hypertensive subjects were followed up for an
verage of 4.9 2.5 years (range 1 to 12 years), representing
n average of 3.1 visits per person. Specifically, 171 partic-
pants had 2 visits, 150 had 3 visits, 71 had 4 visits, 41 had
visits, and 16 had 6 or more visits. For those who were
tarted on antihypertensive medications during the
ollow-up period, their BP data were censored at the last
aseline Characteristics of the Study Cohort
Table 1 Baseline Characteristics of the Study Cohort
Variable Overall Men Women
n 449 201 248
Age (yrs) 53 17 54 17 51 16
Race (white) 348 (77%) 157 (78%) 191 (77%)
Height (cm) 170 10 178 7 163 7*
Weight (kg) 74 16 83 14 67 13*
BMI (kg/m2) 25 4 26 4 25 4†
Smoking (ever) 232 (52%) 115 (57%) 117 (47%)‡
Heart rate (beats/min) 69 12 68 13 69 11
SBP (mm Hg) 125 17 128 17 123 18‡
DBP (mm Hg) 80 10 82 9 78 10*
PP (mm Hg) 46 13 46 13 46 14
MAP (mm Hg) 95 11 97 11 92 11*
PWV (m/s) 6.9 2.5 7.2 2.7 6.7 2.3‡
Cholesterol (mg/dl) 183 38 181 33 184 42
LDL (mg/dl) 112 33 113 30 111 36
HDL (mg/dl) 49 13 43 11 54 13*
Triglycerides (mg/dl) 101 72 117 87 87 52*
Glucose (mg/dl) 97 14 100 16 95 12†
p  0.0001. †p  0.001. ‡p  0.01 compared with men.
BMI  body mass index; DBP  diastolic blood pressure; HDL  high-density lipoprotein;
DL  low-density lipoprotein; MAP mean arterial pressure; PP  pulse pressure; PWV  pulse
ave velocity; SBP  systolic blood pressure.isit on which they were not receiving antihypertensive
Tedications (i.e., the visit immediately preceding the one
ith medications).
WV and longitudinal SBP. We first evaluated the asso-
iation between variables measured at baseline and SBP
easured on the last visit, with multiple regression analyses.
s expected, age, BMI, and MAP were independently
ssociated with higher SBP on the last visit (Table 2); in
ddition, PWV was also independently associated with
igher SBP on the last visit, and explained 4% of its
ariance. Next, we took advantage of the repeated measure-
ents of BP at each follow-up visit to characterize the
ongitudinal changes in SBP over time in our cohort. Using
inear mixed-effects regression models, we evaluated the
redictors of the longitudinal changes in SBP. In these
odels, a statistically significant interaction term be-
ween time and a predictor variable indicates that the
ongitudinal changes in SBP are influenced by this
ariable. As shown in Table 3, age, BMI, and MAP
p  0.09, p  0.009, p  0.0001 respectively for the
nteraction terms with time) were predictors of the longi-
udinal changes in SBP. In addition, PWV was also an
ndependent predictor of the longitudinal increase in SBP
p  0.003 for the interaction term with time). The
ontribution of PWV to the mixed effects models was
valuated by comparing models that included and excluded
WV: after adjusting for the other covariates in the model,
WV accounted for 16% of the variance in the longitudinal
hanges in SBP (20). Of note, the main effect of PWV was
tatistically significant (p  0.006) when the model was run
ithout the interaction term between PWV and time.
Figure 1 provides an example that illustrates the effects
f PWV on the predicted longitudinal increase in SBP.
hen stratified according to age-decade-specific quar-
iles of PWV, a 40-year-old man whose PWV is in the
ighest quartile has, on average, a higher SBP at baseline
han a 40-year-old man whose PWV is in the lowest
uartile (120 mm Hg vs. 111 mm Hg), and an accelerated
ncrease in SBP over the ensuing 10 years (11 mm Hg vs.
ultiple Regression Analysisvaluating th Predictors of Last Visit SBP






Age (yrs) 0.32 0.06 0.0001
Gender (men) 0.65 1.78 0.71
Race (white) 1.22 2.00 0.54
Smoking (ever) 2.48 1.61 0.12
BMI (kg/m2) 0.61 0.22 0.006
MAP (mm Hg) 0.60 0.08 0.0001
PWV (m/s) 1.56 0.38 0.0001
Heart rate (beats/min) 0.08 0.06 0.20
Total cholesterol (mg/dl) 0.005 0.02 0.83
Triglycerides (mg/dl) 0.009 0.01 0.50
HDL cholesterol (mg/dl) 0.001 0.07 0.98
Glucose (mg/dl) 0.02 0.06 0.75
2he predictor variables were all measured at the baseline visit. Model R  0.42.
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WV is in the highest quartile has, on average, a higher
BP at baseline than a 70-year-old man whose PWV is in
he lowest quartile (138 mm Hg vs. 128 mm Hg), and an
ccelerated increase in SBP over the ensuing 10 years (17
m Hg vs. 11 mm Hg) (Fig. 1B).
WV and longitudinal PP. Using mixed-effects linear
egression models, we also evaluated the determinants of the
ongitudinal changes in PP. In the overall cohort, only age
as an independent predictor of the longitudinal increase in
P (p 0.0001 for the interaction term with time), whereas
WV was only a determinant of higher PP (p  0.03), but
ot of longitudinal changes in PP (Online Table 1). This is
ikely related to accelerated increases in DBP among
ounger individuals with higher PWV (data not shown),
hich balance the longitudinal increases in SBP. Indeed,
hen the analyses were repeated after stratifying the cohort
nto tertiles of age, PWV was an independent predictor of
he longitudinal increase in PP (p 0.04 for the interaction
redictors of Longitudinal SBP Derived From a Linear Mixed-Effects
Table 3 Predictors of Longitudinal SBP Derived From a Linear M
Variable Coefficient Standardized
Time (yrs) 3.14 0.1
Age (yrs) 0.37 0.2
Age2 (yrs2) 0.006 0.0
Gender (men) 0.61 0.0
BMI (kg/m2) 0.25 0.1
MAP (mm Hg) 1.03 0.4
PWV (m/s) 0.29 0.1
Time  age 0.02 0.0
Time  BMI 0.10 0.0
Time  MAP 0.08 0.1
Time  PWV 0.22 0.0
he model also included race, smoking, heart rate, cholesterol, HDL, triglycerides, and glucose, w
Abbreviations as in Table 1.
Figure 1 Baseline and Predicted 10-Year Longitudinal Changes
Baseline and predicted 10-year longitudinal changes in systolic blood pressure (SB
ity (PWV) at baseline was in the highest versus lowest quartile. For both starting a
increase in SBP compared with men whose PWV was in the lowest quartile. Quartierm with time) among individuals over the age of 60 years
highest tertile) (Online Table 2).
WV as a predictor of incident hypertension. Because
WV was an independent determinant of the longitudinal
ncrease in SBP, we next evaluated whether PWV could also
redict the future development of HTN among the 306
ndividuals from our cohort who were normotensive at the
aseline visit, during which PWV was assessed. Over a
edian follow-up of 4.3 years (mean 4.7  2.5 years, range
to 12 years), HTN developed in 105 (34%). Of note,
nlike the preceding set of analyses, censoring was not
erformed on the visit preceding the one with medication.
The baseline characteristics of the subjects who remained
ormotensive during follow-up versus those in whom hy-
ertension developed, stratified according to median
ollow-up duration, are shown in Table 4. The predictors of
ncident HTN were evaluated with stepwise Cox models, in
hich age and baseline SBP were forced into the models. In
he group with shorter follow-up duration, no other variable
ression Model
-Effects Regression Model
ient 95% Confidence Interval p Value
0.61 to 5.66 0.02
0.68 to0.06 0.02
0.002 to 0.008 0.0001
1.26 to 2.47 0.52
0.01 to 0.50 0.06
0.93 to 1.12 0.0001
0.16 to 0.74 0.21
0.002 to 0.038 0.09
0.02 to 0.183 0.009
0.11 to0.05 0.0001
0.07 to 0.36 0.003
re all nonsignificant.
P
men with starting ages 40 years (A) and 70 years (B) whose pulse wave veloc-
en whose baseline PWV was in the highest quartile showed an accelerated
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April 8, 2008:1377–83 Pulse Wave Velocity and Blood Pressureas significant when added to the model. In contrast, in the
roup with follow-up duration greater than the median (in
hich all subjects remained normotensive for the first 4.3
ears), beyond age (hazard ratio [HR] 1.02 per 1 year, 95%
onfidence interval [CI] 0.99 to 1.04, p  0.2) and SBP
HR 1.05 per 1 mm Hg, 95% CI 1.01 to 1.09, p  0.006),
oth HDL (HR 0.96 per 1 mg/dl, 95% CI 0.93 to 0.99,
 0.02) and PWV (HR 1.10 per 1 m/s, 95% CI 1.00 to
.30, p  0.03) (Fig. 2) were independent predictors of
ncident HTN.
iscussion
he main findings of this study are that PWV, a marker of
entral arterial stiffening, is an independent determinant of
ongitudinal SBP increase in healthy BLSA volunteers, and
n independent risk factor for incident hypertension among
ormotensive subjects followed up for longer than 4 years.
rterial stiffness as a predictor of HTN. At least 2 prior
tudies have identified indices of central arterial stiffness
hat predicted future HTN in normotensive community-
ased samples. Liao et al. (21) previously showed that in
ormotensive middle-aged (45 to 64 years) participants in
he Atherosclerosis Risk in Communities (ARIC) Study,
ndexes of carotid arterial elasticity were independent pre-
ictors of future HTN over a 6-year mean follow-up. Simi-
arly, Dernellis and Panaretou (22) showed that echocardio-
raphic indexes of aortic stiffness were independent predictors
f incident HTN in normotensive subjects across a broad age
aseline Characteristics of the 306 Subjects Who Were Normotensollow-Up Du tion (4.3 Years) and Whether They Remained N rmo
Table 4
Baseline Characteristics of the 306 Subjects Who We
Median Follow-Up Duration (4.3 Years) and Whether T
During Follow-Up
Follow-Up Duration <4.3 Years (Average 2
NTf HTNf
N 93 69
Age (yrs) 44 14 62 15
Gender (men) 30 (32%) 34 (49%)
Race (white) 66 (76%) 49 (71%)
Height (cm) 170 7.1 169 8.0
Weight (kg) 72 7.3 73 8.1
BMI (kg/m2) 24 0.55 26 0.54
Smoking history (%) 45 (48%) 36 (52%)
Heart rate (beats/min) 69 0.52 69 0.55
SBP (mm Hg) 116 3.8 121 3.9
DBP (mm Hg) 75 1.4 76 1.5
PP (mm Hg) 413.4 453.7
MAP (mm Hg) 89 1.9 91 1.8
PWV (m/s) 5.8 1.1 7.3 1.2
Cholesterol (mg/dl) 170 11 184 12
LDL (mg/dl) 102 8.2 113 8.3
HDL (mg/dl) 49 5.5 50 6.2
Triglycerides (mg/dl) 85 17.3 100 17.1
Glucose (mg/dl) 95 3.0 96 3.3
These subjects remained normotensive for the first 4.3 years. †Adjusted for age and gender.
Abbreviations as in Table 1.pan (35 to 94 years) who were followed up for 4 years.Our findings are in agreement with these 2 previous
tudies and extend them insofar as we show, for the first
ime, that PWV, one of the most widely used indexes of
entral arterial stiffness, is also an independent predictor of
n the Baseline Visit, Stratified According to Medianive (NTf) or Developed Hypertension (HTNf) During
rmotensive on the Baseline Visit, Stratified According to
emained Normotensive (NTf) or Developed Hypertension (HTNf)
.8) Follow-Up Duration >4.3 Years (Average 6.9  1.7)
Value NTf HTNf* p Value
108 36
.0001 44 14 53 14 0.0006
.02 39 (36%) 20 (55%) 0.03
.72† 90 (83%) 27 (77%) 0.4†
.73† 170 6.5 172 6.9 0.15†
.35† 70 8.0 73 8.4 0.05†
.0001† 24 0.93 25 0.96 0.006†
.48† 56 (52%) 15 (43%) 0.35†
.60† 68 1.3 67 1.4 0.001†
.0001† 114 10 116 14 0.0001†
.0023† 75 2.1 76 2.2 0.10†
.0001† 392.1 402.3 0.07†
.0001† 88 1.8 89 1.8 0.006†
.0001† 6.0 0.9 6.7 1.0 0.0005†
.0001† 173 7.3 178 7.3 0.001†
.0001† 104 6.6 109 6.9 0.13†
.52† 49 3.9 48 4.1 0.11†
.0001† 86 10.1 90 10.5 0.02†
.02† 96 1.9 97 2.0 0.0001†
Figure 2 Adjusted Hypertension-Free Survival Curves for
Participants Who Were Followed Up for >4.3 Years
All participants were normotensive at 4.3 years and were stratified according to
median PWV (5.8 m/s). The curves are adjusted for age, SBP, and high-density
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Pulse Wave Velocity and Blood Pressure April 8, 2008:1377–83uture HTN. Furthermore, our results show for the first
ime that PWV is an independent determinant of the
ongitudinal increase in SBP as a continuous variable, that
s, beyond the arbitrary threshold values that are used to
efine HTN. It is worth noting that unlike the ultrasono-
raphically derived indexes of carotid and aortic distensibil-
ty that were used in the 2 prior studies (21,22), PWV has
een shown to be an independent risk factor for cardiovas-
ular morbidity and mortality in diverse populations (5–10).
The finding that PWV was a predictor of incident HTN
nly in subjects with a follow-up duration 4 years but not
n subjects with a shorter follow-up duration is not surpris-
ng because the increase in BP that is attributable to the
igher arterial stiffness is expected to be a gradual process.
e cannot exclude the possibility that our sample size was
nderpowered to discern the independent predictive effects
f PWV in the group with the shorter follow-up duration,
articularly because our models were adjusted for age and
aseline SBP.
BP as a predictor of arterial stiffness. It is traditionally
elieved that arterial stiffening is accelerated by higher SBP
ecause of the structural and functional alterations in the
alls of the central elastic arteries in response to the
hronically elevated distending pressures (13). In the Fra-
ingham Heart Study (23), the longitudinal increase in
ulse pressure, a surrogate measure of arterial stiffness, was
reater in subjects with higher baseline SBP. In the Boga-
usa Heart Study (24), the cumulative burden of SBP
easured since childhood and over an average follow-up of
6.5 years was an independent predictor of brachial-ankle
WV measured in young adulthood. However, this analysis
as not adjusted for baseline arterial stiffness because the
atter was not assessed during childhood.
Importantly, 2 longitudinal studies of carotid–femoral
WV that did adjust for baseline arterial stiffness did not
nd SBP to be an independent predictor of the longitudinal
hanges in PWV. Benetos et al. (25) found that after a
-year follow-up, SBP was not an independent predictor of
WV increase among normotensive or hypertensive sub-
ects, although the increase of PWV in poorly controlled
ypertensive subjects was significantly greater than that in
ell-controlled hypertensive subjects and in normotensive
ubjects. Wildman et al. (26) found that after a 2 year
ollow-up, SBP was not associated with the annual change
n PWV, even by univariate analyses. In contrast, our
resent study and those by Liao et al. (21) and Dernellis and
anaretou (22) collectively provide robust evidence of the
onverse, namely that arterial stiffening precedes and pre-
isposes to accelerated longitudinal increases in SBP and to
uture HTN. In other words, arterial stiffening is not simply
n adaptive response of blood vessels to distending pres-
ures; rather, when it is accelerated, arterial stiffening is
n underlying pathophysiological cause of the increase in
ressure.
mplications. Although studies attempting to characterize
ormotensive populations at risk for the development of pTN have largely focused on measurements of BP (27), our
esults suggest that PWV could potentially serve as a
aluable additional tool to help in risk stratifying these
ndividuals. Furthermore, because PWV is a risk factor for
ncident HTN efforts to find cost-effective and efficacious
e-stiffening interventions should be intensified. Tradition-
lly, the age-associated increase in arterial stiffness has been
ttributed to cumulative wear-and-tear induced fragmenta-
ion and depletion of elastin, as well as the deposition of
ollagen (13). Recent findings suggest that central arterial
tiffness is also regulated by other processes (28), including
lterations in the signaling cascades of nitric oxide,
ndothelin-1, and other putative cell-signaling molecules.
uture studies are needed to determine whether interven-
ions that target these pathophysiological processes can
ucceed in preventing or delaying the onset of HTN.
tudy limitations. The BLSA participants tend to be
redominantly white, well-educated, and health-conscious
ndividuals, which limits the generalizability of our findings
o other populations. Our study only included measure-
ents of brachial BP, which are overestimates of central
BP and PP caused by pressure wave amplification across
he arterial tree. However, central BP is seldom available in
linical practice, and is rarely assessed in epidemiological
nd longitudinal studies of BP. Because the diagnosis of
ypertension was made by the presence of antihypertensive
edications in 44% of subjects in whom hypertension
eveloped during follow-up, we were not able to evaluate
hether PWV’s ability to predict hypertension varied ac-
ording to the type of hypertension (i.e., systolic vs. diastolic
s. mixed). Because of the important effect of distending
ressures (MAP) on arterial stiffness, adjusting the mixed-
ffects models for baseline MAP is necessary (and is one of
he strengths of this analysis); however, this could introduce
bias in favor of the estimated coefficient of PWV because
AP is closely related to the outcome of interest (29).
onclusions
e found that arterial stiffness, as indexed by PWV, is an
ndependent predictor of the longitudinal increase in SBP
nd of incident HTN. Because higher SBP and established
TN are associated with significant cardiovascular morbid-
ty and mortality (2,3), our findings suggest that PWV could
otentially serve as a screening tool to identify normotensive
ndividuals at higher risk, who could be targeted for phar-
acological and nonpharmacological interventions aimed at
reventing or delaying the progression of subclinical arterial
tiffening and the onset of HTN.
cknowledgments
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